A month ago this masthead covered Orora taking 108 grams out of a standard Riesling bottle, made solely on the oxy-fuel furnace at Gawler. Four weeks later the same company reported the largest write-down in its history against its glass division. Those two facts sit oddly together until you read which glass the results are talking about, and the answer is not the one in South Australia.

The headline numbers

Orora FY26, year ended 30 June 2026, continuing operations
MeasureFY26Change
Revenue$2,225.9m+6.5%
EBITDA$420.3m+0.3%
EBIT$248.2m−5.3%
Underlying NPAT$142.2m−5.9%
Statutory NPATloss of $616.6mn/a
Earnings per share11.4cflat
Total FY26 dividends9.0c78% payout
Underlying operating cash flow$290.7m98.3% realisation

Source: Orora FY26 Results Investor Release, ASX announcement, 13 August 2026.

The gap between a $142.2 million underlying profit and a $616.6 million statutory loss is the significant-item expense of $758.8 million after tax, of which the Glass impairment is $728.2 million after tax. The $742.8 million the chief executive quotes is the pre-tax figure for the same event. Both appear in the same release and they are not two write-downs.

Which glass, and this is the part worth reading carefully

Orora reports glass in three lines, and they moved in different directions.

Orora segment results, FY26 against FY25, A$ million
SegmentFY26 revenueVarFY26 EBITDAVar
Cans880.0+13.3%131.2+10.5%
Saverglass1,061.4+3.3%226.8−6.8%
Gawler284.5−0.3%62.3+9.5%
Global Glass total1,345.9+2.5%289.1−3.7%
Group2,225.9+6.5%420.3+0.3%

Source: Orora FY26 Results Investor Release, financial summary, continuing operations.

Gawler grew earnings 9.5 per cent on revenue that went nowhere. That is the Australian glass plant, the one running the oxy-fuel furnace and the one that will make the lightweight Riesling bottle. Saverglass, the French-headquartered business Orora bought in 2023, grew revenue 3.3 per cent and lost 6.8 per cent of its EBITDA. The impairment is against the Glass business comprising Saverglass goodwill and other assets, and the company is explicit that it follows a reassessment relative to our 2023 acquisition.

So an Australian wine bottler reading a headline about a three-quarter-billion-dollar glass write-down should understand what it is and is not. It is an accounting reassessment of what an acquired international business is worth on the balance sheet. It is not cash leaving the business, and on these numbers it is not a statement about the plant at Gawler.

What Orora says is behind it

The company’s stated causes are demand-side and external. Chief executive Brian Lowe says spirits and wine volumes remain challenged across most geographies, with cost-of-living pressures impacting premiumisation trends, and that Saverglass volumes actually rose 5.9 per cent while revenue and earnings absorbed the negative impacts of within-category mix, lowering average selling price and margins. In plain terms, the bottles sold but the expensive ones sold less well, and glass is a business where the mix is the margin.

He names three external pressures on recent earnings: US tariffs, the ongoing Middle East conflict and cost-of-living pressures across key markets. The reassessment that followed was of timing rather than of the asset’s prospects: the company says it has revised our view on the timing of the recovery in consumer demand and Saverglass earnings while maintaining that the business retains attractive medium-term growth prospects.

Against that, cans had the year. Volumes rose 6.3 per cent on what Lowe calls the continued consumer preference shift to aluminium and growth in new beverage categories, and underlying cans EBITDA rose 14.7 per cent. For a packaging trade that has watched the aluminium-versus-glass question for a decade, this is one company’s numbers putting a figure on it in a single year.

What happens next, in the company’s own terms

Orora says its major capital expenditure cycle is complete and the investments are shifting from capital investment to cash generation. The glass business is running six initiatives targeting more than €30 million of net EBIT run-rate improvement by FY30, which is a five-year horizon on a business just written down. More than $117 million went back to shareholders through buybacks during the year, and the buyback resumes.

What the Annual Report adds, and the release did not

The results release is a summary. Orora’s Annual Report 2026, published the same day, carries the impairment note behind it, and it answers three questions the release leaves open: what exactly was written off, what assumptions produced the number, and whether there is more to come.

First, the $742.8 million is two things, not one. Note 2.7.1 records an impairment of $732.8 million against the Glass cash-generating unit, resulting in a reduction to goodwill of $686.8 million, brand name of $29.5 million and other intangibles of $16.5 million. The remaining $10.0 million is a separate write-down of certain items of property, plant and equipment in the Glass segment, following an assessment of individual asset recoverability. Add them and you get the headline figure. Nearly all of it, $686.8 million, is goodwill: the premium paid over the value of the assets themselves.

Second, the goodwill on that unit is now gone entirely. The assumptions table puts Glass CGU goodwill at $744.7 million at 30 June 2025 and shows nothing against it at 30 June 2026. Brand name went from $460.3 million to $394.7 million. What remains on the balance sheet for the Glass business is a brand, not a premium.

Glass CGU: indefinite life assets and the assumptions behind them
Glass CGUFY25FY26
Goodwill$744.7mnil
Brand name$460.3m$394.7m
Pre-tax discount rate10.2%11.8%
Post-tax discount rate8.2%9.0%
Terminal growth rate2.0%2.1%
Assumed volume CAGR5.4%3.7%

Source: Orora Annual Report 2026, note 2.7.1, key assumptions used in value-in-use calculations. Rates are weighted averages.

Third, and this is the part a buyer should take from it, two different things moved. The report attributes the write-down to lower forecast sales volumes, an adverse shift in product mix and lower average selling prices resulting in reduced margins, and the forecast volume growth rate was cut to an anticipated volume CAGR of 3.7% (2025: 5.4%). But the pre-tax discount rate applied to those cash flows also rose, from 10.2 per cent to 11.8 per cent. A higher discount rate reduces the present value of the same future earnings, so part of this impairment is the cost of capital rather than the trading performance. The report does not split the two, and neither can we from what is published.

And there may be more. Having written the goodwill off, the company does not describe the matter as closed. The note says that the impairment assessment remains sensitive to changes in any assumption and that additional impairments may arise if future trading performance differs from current forecasts. That is a standard form of words, but it is doing real work here: $394.7 million of brand name is still carried against a unit whose recoverable amount was just found wanting.

Orora’s own position is that the strategy has not changed. The Chair writes that the outcome does not change the underlying strategic rationale for the Saverglass acquisition or the long-term role of premium glass in the portfolio, while saying it raises the importance of executing the glass plan. Worth noting alongside that: FY26 is not the first year glass has cost Orora a significant item. In FY25 the company recorded $83.7 million on the Asia Pacific glass production capacity review and $34.2 million on the European glass restructure, $117.9 million between them, and FY26 adds a further $25.5 million of European glass restructure on top of the impairment. This is the third consecutive year in which glass has carried the significant items.

What we are not saying

We have not audited any of these figures and we are reporting a listed company’s own released numbers, attributed. A non-cash impairment is a judgement about carrying value, and reasonable people price acquisitions differently; nothing here says the 2023 purchase was wrong, only what the company now records it as worth. We have not spoken to Orora, and the FY30 target and the recovery timing are the company’s expectations rather than established facts. Nothing here is a claim about any individual.

How we sourced this

Updated 24 August 2026. As first published on 19 August, every figure came from Orora’s FY26 Results Investor Release alone. That is one document from the announcing company, so we went back for the Annual Report 2026, a 13 MB pdf published the same day, and read the impairment note behind the headline. The section above is drawn from it: the split of the $742.8 million, the assumptions table, and the sensitivity language. The original figures are unchanged; the report explains them rather than correcting them.

Figures in the earlier sections are taken from Orora’s FY26 Results Investor Release, an ASX announcement dated 13 August 2026, downloaded and read on 19 August 2026, and from the company’s own news page carrying the same release. The segment table is transcribed from the financial summary for continuing operations. Where the release states an impairment both pre-tax and after tax we have given both and said which is which, because the two figures describe one event.

Sources

  1. Orora Limited, Orora’s Full Year Financial Results 2026 and the linked FY26 Results Investor Release (ASX announcement, 13 August 2026, PDF downloaded and read 19 August 2026): the figures and quotations in the sections above the Annual Report section, including the statutory loss, the impairment stated pre-tax and after tax, the segment table, and the chief executive’s remarks.
  2. Orora Limited, Annual Report 2026 (pdf, 13 MB, published 13 August 2026, downloaded and read 24 August 2026): note 2.7.1 goodwill and brand name impairment tests, including the $732.8 million charge against the Glass CGU and its split between goodwill, brand name and other intangibles; the separate $10.0 million property, plant and equipment write-down in the Glass segment; the key-assumptions table giving pre-tax and post-tax discount rates, terminal growth rates and carrying amounts for FY25 and FY26; the assumed volume CAGR; the stated causes of the revision; the sensitivity language on further impairments; note 1.4 significant items for FY26 and FY25; and the Chair’s statement on the strategic rationale for the Saverglass acquisition.
  3. Our own report on the AG244 lightweight Riesling bottle (20 July 2026): the Gawler oxy-fuel furnace and the bottle that plant is to make, for the contrast drawn above.

Closer to glass supply or packaging finance than we are, or read these results differently? The correction form is on our tips page; we check every correction against the published release and log the outcome here.